CAV Regimen (Etoposide, Lomustine & Melphalan)

Known as: CAV regimen 
 

Topic mentions per year

Topic mentions per year

1982-2009
01219822009

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
AIM The number of elderly patients with small cell lung cancer (SCLC) is expected to increase with the growing geriatric… (More)
Is this relevant?
2003
2003
Rapid allergen vaccination (RAV) is the updated term for what was previously called rush immunotherapy and rapid desensitization… (More)
Is this relevant?
2002
2002
This randomized study of previously untreated patients with extensive disease small cell lung cancer was designed (a) to compare… (More)
Is this relevant?
2001
2001
BACKGROUND Information on the effect of chemotherapy in a group of patients with poor prognosis, poor performance status small… (More)
Is this relevant?
1994
1994
BACKGROUND A prospective study was conducted to assess the efficacy and toxicity of a salvage regimen consisting of CCNU… (More)
Is this relevant?
1992
1992
BACKGROUND Studies have shown that response to a given chemotherapy in previously untreated patients with extensive-stage small… (More)
Is this relevant?
Highly Cited
1991
Highly Cited
1991
Between April 1985 and May 1988, we conducted a randomized study comparing two standard chemotherapy regimens with the same… (More)
Is this relevant?
1990
1990
A dose-intensive, cyclophosphamide (CPM)-based chemotherapy regimen was tested in 22 children with newly diagnosed metastatic or… (More)
Is this relevant?
1990
1990
In this randomized study involving patients with limited-stage small-cell lung cancer (LD-SCC), we compared treatment with either… (More)
Is this relevant?
1982
1982
Chemotherapy with a combination of cisplatin (60 mg/m2), Adriamycin (45 mg/m2), and etoposide (120 mg/m2 X 3) (CAV) has been… (More)
Is this relevant?